|
|
By Mark Ginestro and Jay Zhu, EY
Amid continuing focus on environmental, social, and governance (ESG) priorities among investors across every industry, medtech companies need to begin revisiting business models and developing new sustainability strategies for maintaining a competitive edge as well as regulatory compliance.
|